-
Cart: 0 Items 0
My Cart
0 ItemsYour cart is empty
Subtotal :$0 USD
Dual GIP/GLP-1 receptor agonist prescribed via telehealth. Clinically proven for superior weight loss results.
Start Your Free Consultation →Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that represents the next generation of medical weight loss therapy. Originally approved for type 2 diabetes as Mounjaro, it has since gained FDA approval for chronic weight management as Zepbound. Tirzepatide works on two incretin pathways simultaneously, producing greater weight loss results than GLP-1-only medications.
In clinical trials (SURMOUNT-1), patients on tirzepatide lost up to 22.5% of body weight — the largest weight reduction ever recorded in an obesity medication trial. FYRE Body prescribes compounded tirzepatide shipped monthly to your door.
| FYRE Body (Online) | Traditional Clinic | |
|---|---|---|
| Consultation fee | $0 | $200–$500 |
| Average weight loss | Up to 22.5% | 5–10% (typical clinic programs) |
| Wait time | 24–48 hours | 2–6 weeks |
| Office visits required | None | Multiple |
| Pharmacy | U.S. compounding, shipped to door | Specialty pharmacy pickup |
| Ongoing support | 7-day provider messaging | Office hours only |
This treatment may be appropriate for men who:
Tirzepatide is not appropriate for everyone. Patients with a history of medullary thyroid carcinoma, MEN2 syndrome, or severe gastrointestinal disease should not take GIP/GLP-1 medications. A licensed provider will evaluate your eligibility.
How is tirzepatide different from semaglutide?
Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide targets GLP-1 only. Clinical trials show tirzepatide produces approximately 5–7% more weight loss than semaglutide at comparable doses.
Is this the same as Mounjaro or Zepbound?
Tirzepatide is the active ingredient in both Mounjaro (diabetes) and Zepbound (weight management). FYRE Body prescribes compounded tirzepatide at equivalent therapeutic doses.
How often do I inject?
Tirzepatide is a once-weekly subcutaneous injection. Needles, supplies, and instructions are included with every shipment.
What are the common side effects?
Nausea and GI discomfort during dose escalation are most common, typically resolving within a few weeks. Your provider titrates slowly to minimize side effects.
Can I switch from semaglutide to tirzepatide?
Yes. Many patients switch for enhanced results. Your provider will create a safe transition plan with appropriate dosing.
How much does it cost?
Tirzepatide through FYRE Body is $375/month, including medication, needles, supplies, and overnight refrigerated shipping. No hidden fees.
Free consultation. No office visits. Prescribed by board-certified providers.
Get Started Free →